BMAA decreases cell proliferation. by Bryan Burton (14768907)

“…<p>Treatment of IMR-32 cells with increasing doses of BMAA over a 24 hour period resulted in decreased cell number and inhibition of cell proliferation as determined by microscopy and quantified by XTT assay (A and B). …”

Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”

Statistically-significant cytokine changes between the pre-infusion and post-infusion blood draws plot of the mean (dot) and confidence interval (whiskers) for the coefficients of... by Jordan K. Abbott (8934239)

Subjects:

The density of PNN in HVC is no longer decreased 4 months after treatment with ChABC. by Gilles Cornez (718394)

Hydroxychloroquine treatment decreases LAMP3-induced cell death <i>in vivo</i>. by Hiroyuki Nakamura (200082)

Interluekin-4 (IL-4) treatment upregulates SIRPA expression and decreases viral internalization. by Nicolás Sarute (582477)

NRH treatment dose-dependently decreased the number of surviving HepG3 cells. by Manoj Sonavane (5340581)

Mean platelet volume and neutrophil to lymphocyte ratio decrease in patients with depression with antidepressant treatment by AHMET ÖZTÜRK (8077292)

“…Conclusion Decreasing MPV and NLR values with the treatment of depression confirm the involvement of inflammatory processes in the pathophysiology of depression.…”

Treatment with TDF decreased cell viability and induced morphological changes in hepatic stellate cells. by Sung Won Lee (222509)

Pre-treatment of OJS did not mitigate DRG activation but decreased inflammatory responses in BMDM. by Patrice Cunningham (12914917)

Identification of ACADM, ANGPTL4, and NFKB2 as significant predictors of OS in the TCGA-KIRC cohort. by Yu Zhang (12946)

Subjects:

Decreasing fluconazole susceptibility of clinical South African <i>Cryptococcus neoformans</i> isolates over a decade by Serisha D. Naicker (8648370)

The evaluation of the CAFs marker on each treatment day. by Yoshiaki Tadokoro (16851585)

Subjects:

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Bexarotene pretreatment significantly suppressed HBV and HDV infections in primary human hepatocytes (PHH). by Sameh A. Gad (12269979)

Effect of busulfan treatment on androgens and androgen receptors. by Lingjun Zhao (21763122)

“…<p>Enzyme-linked immunosorbent assay results for A) androgens and B) androgen receptors. The androgen concentration remains stable after busulfan treatment, but the androgen receptor concentration significantly decreases 21 days after treatment. …”

The effect of transcutaneous CO₂ treatment. by Yoshiaki Tadokoro (16851585)

Subjects:

Active organic carbon components before and after mineralization. by Jie Wei (264772)

Subjects:

FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

“…<p>(A) Following 24 hours of treatment with FTY720, the viability of HuH6 cells measured using the alamarBlue cell viability assay was significantly decreased (LD₅₀ = 8.4 μM, p ≤ 0.05). …”

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA.... by Emir Matpan (21655811)

“…Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. …”